A compound produced by cannabis plants has been found to kill drug-resistant bacteria.
Hopes have been raised in the medical community following the discovery that cannabigerol (CBG), a compound made by cannabis plants, could be a new way combat superbugs, The Guardian reports.
The compound has been found to have antibiotic properties and be effective at destroying methicillin-resistant Staphylococcus aureus (MRSA) – one of the most common hospital bugs that cause skin infections and deadly sepsis.
CBG, which doesn’t cause one to feel “high”, can kill the MRSA microbes and break down cells that are especially resistant to antibiotics which often drive repeat infections.
Researchers also tested CBG’s for treating infections in animals and found it to be effective against MRSA infections in mice.
Eric Brown, the research leader at McMaster University in Canada, said cannabinoids were “clearly great drug-like compounds”, but that it was still early days in assessing the compounds for human use.
“There’s much work to do to explore the potential of the cannabinoids as antibiotics from the safety standpoint,” he said.
Breakthroughs in antibiotics research will probably be held back from development for human use to minimise the risk of bacteria developing resistance, according to the Independent.
The study hasn’t yet been published but is undergoing review at the ACS Infectious Diseases Journal.